Google, Novartis Partner To Revolutionize HealthcareMark Melin
Google Inc (NASDAQ:GOOG) (NASDAQ:GOOGL) and Swiss drugmaker Novartis AG (ADR) (NYSE:NVS) (VTX:NOVN) have announced an amazing development, one sure to be a significant point of differentiation in Google’s plans to beat Apple Inc. (NASDAQ:AAPL) and Samsung Electronics Co. Ltd. (LON:BC94) (KRX:0059935) in the race to control consumers healthcare applications.
The product under joint development is “smart” contact lenses that track blood glucose levels or restore the . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email firstname.lastname@example.org and we will get back to you as quick as humanly possible